Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MyocardON-TTR - Myocardial Effects in Patients With Hereditary Transthyretin-mediated Amyloidosis With Polyneuropathy Treated With Patisiran or Vutrisiran

NCT05873868 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT05873868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05873868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MyocardON-TTR - Myocardial Effects in Patients With Hereditary Transthyretin-mediated Amyloidosis With Polyneuropathy Treated With Patisiran or Vutrisiran
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
April 12, 2024
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, hereditary, transthyretin amyloidosis